[Comparative anti-rickettsial effects of spiramycin (RP 5337) with aureomycin and terramycin].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D002751:Chlortetracycline; D003879:Dermatologic Agents; D010118:Oxytetracycline / Q000627:therapeutic use*; D011500:Protein Synthesis Inhibitors; D012282:Rickettsia Infections / Q000628:therapy*; D015572:Spiramycin; D013752:Tetracycline / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D011500:Protein Synthesis Inhibitors; D015572:Spiramycin; D013752:Tetracycline; D002751:Chlortetracycline; D010118:Oxytetracycline
ANTIBIOTICS/therapeutic use; OXYTETRACYCLINE/therapeutic use; RICKETTSIAL DISEASES/therapy; TETRACYCLINE/therapeutic use
Comparaison de l'action antirickettsienne du 5337 RP ou spiramycine avec celle de l'aureomycine et de la terramycine.